VERASTEM, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.6 USD | +2.35% |
|
-2.46% | +16.71% |
| 04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
| 04-18 | Verastem Oncology Announces Executive Changes | CI |
Chart calendar Verastem, Inc.
c170e593bafb65d8.z4L8jK1Rg4qTLZcEnbKiy828frGVzOoL0toM4Hk5o-A.n9qd9fk94Mj-e6BRpYPyvILdEtjzg7pzg51GmQ5A5LGW-KWhxQvX3slD_A~5f47decfc4644aa745da2538a0f4478e
Upcoming events on Verastem, Inc.
Past events on Verastem, Inc.
| 10/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract #: 7268 |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract #: 4745 |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract #: 4127 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract #: 3318 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract #: 3318 |
| 18/03/2024 18:45 | Society of Gynecologic Oncology Meeting - Charlotte C |
| 18/03/2024 18:45 | Society of Gynecologic Oncology Meeting - Rachel N |
| 17/03/2024 23:15 | Society of Gynecologic Oncology Meeting |
| 17/03/2024 20:45 | Society of Gynecologic Oncology Meeting |
| 14/03/2024 20:05 | Q4 2023 Earnings Release |
| 18/01/2024 21:00 | B. Riley Securities Oncology Conference |
| 17/01/2024 14:00 | Extraordinary Shareholders Meeting |
| 08/11/2023 21:12 | Q3 2023 Earnings Release |
| 04/11/2023 | International Gynecologic Cancer Society Meeting |
| 26/09/2023 14:55 | Cantor Global Healthcare Conference |
| 12/09/2023 19:00 | H.C. Wainwright Global Investment Conference |
| 08/08/2023 21:05 | Q2 2023 Earnings Release |
| 05/06/2023 19:15 | American Society of Clinical Oncology Conference - Abstract #: 5515 |
| 31/05/2023 | Reverse Split: 1 of 12 |
| 17/05/2023 19:05 | RBC Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,5 16,3 7.23% | 88,5 54,6 62.1% | 2,05 1,47 39.72% | 2,60 2,66 -2.55% | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -132 -126 -5.32% | -49,4 -30,7 -60.98% | -61,4 -58,0 -5.91% | -72,9 -74,3 1.87% | -92,1 -82,5 -11.66% | -119 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -149 -140 -6.96% | -67,5 -62,3 -8.47% | -71,2 -70,6 -0.86% | -73,8 -75,3 1.97% | -87,4 -82,2 -6.32% | -130 |
|
Net income Million USD | Released Forecast Spread | -149 -140 -6.96% | -67,7 -62,3 -8.78% | -71,2 -70,6 -0.86% | -73,8 -75,3 1.97% | -87,4 -81,8 -6.75% | -130 |
|
EPS USD | Released Forecast Spread | -24,0 -22,6 -6.19% | -5,28 -4,86 -8.64% | -4,92 -4,76 -3.36% | -4,56 -4,72 3.39% | -3,96 -3,55 -11.47% | -4,24 |
| Announcement Date | 11/03/20 | 18/03/21 | 28/03/22 | 14/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,55 0,00 - | 2,60 1,50 73.07% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,02 - | 0,00 0,02 - | 0,00 0,03 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,5 -13,5 -22.06% | -17,0 -15,6 -8.79% | -21,4 -20,1 -6.58% | -17,7 -22,0 19.68% | -16,8 -19,2 12.29% | -19,3 -17,8 -8.96% | -20,3 -19,1 -6.12% | -21,3 -20,7 -2.95% | -31,1 -22,0 -41.65% | -29,0 | -29,8 | -30,8 | -31,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,5 -17,5 5.98% | -17,0 -15,6 -8.81% | -22,0 -20,3 -8.05% | -18,1 -22,4 19.07% | -16,8 -19,5 13.72% | -15,7 -17,7 11% | -24,3 -20,5 -18.59% | -20,0 -21,6 7.46% | -27,4 -22,0 -24.22% | -30,6 | -31,5 | -32,0 | -32,9 |
|
Net income Million USD | Released Forecast Spread | -16,5 -17,5 5.98% | -17,0 -15,6 -8.81% | -22,0 -20,3 -8.05% | -18,1 -22,4 19.07% | -16,8 -19,5 13.72% | -15,7 -17,7 11% | -24,3 -20,5 -18.59% | -20,0 -21,6 7.46% | -27,4 -22,0 -24.22% | -30,6 | -31,5 | -32,0 | -32,9 |
|
EPS USD | Released Forecast Spread | -1,20 -1,20 0% | -1,08 -0,98 -9.76% | -1,44 -1,32 -9.09% | -1,08 -1,46 26.03% | -0,96 -1,18 18.37% | -0,96 -1,00 4% | -1,37 -1,06 -29.25% | -0,75 -0,90 16.9% | -1,02 -0,81 -25.54% | -1,16 | -1,08 | -1,04 | -1,02 |
| Announcement Date | 28/03/22 | 09/05/22 | 08/08/22 | 03/11/22 | 14/03/23 | 09/05/23 | 08/08/23 | 08/11/23 | 14/03/24 | - | - | - | - |
More events
Past sector events for Verastem, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VSTM Stock
- Calendar Verastem, Inc.
